Works by Wright, John J.

Results: 51
    1
    2
    3

    Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non-Small-Cell Lung Cancer: A California Cancer Consortium Trial.

    Published in:
    Clinical Lung Cancer, 2011, v. 12, n. 1, p. 33, doi. 10.3816/CLC.2011.n.004
    By:
    • Lara, Jr, Primo N.;
    • Longmate, Jeff;
    • Reckamp, Karen;
    • Gitlitz, Barbara;
    • Argiris, Athanassios;
    • Ramalingam, Suresh;
    • Belani, Chandra P.;
    • Mack, Philip C.;
    • Lau, Derick H. M.;
    • Koczywas, Mariana;
    • Wright, John J.;
    • Shepherd, Frances A.;
    • Leighl, Natasha;
    • Gandara, David R.
    Publication type:
    Article
    4
    5

    Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer.

    Published in:
    Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 1, doi. 10.1007/s00262-009-0782-8
    By:
    • Gulley, James L.;
    • Arlen, Philip M.;
    • Madan, Ravi A.;
    • Kwong-Yok Tsang;
    • Pazdur, Mary P.;
    • Skarupa, Lisa;
    • Jones, Jacquin L.;
    • Poole, Diane J.;
    • Higgins, Jack P.;
    • Hodge, James W.;
    • Cereda, Vittore;
    • Vergati, Matteo;
    • Steinberg, Seth M.;
    • Halabi, Susan;
    • Jones, Elizabeth;
    • Chen, Clara;
    • Parnes, Howard;
    • Wright, John J.;
    • Dahut, William L.;
    • Schlom, Jeffrey
    Publication type:
    Article
    6
    7
    8

    Functional basis of electron transport within photosynthetic complex I.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25527-1
    By:
    • Richardson, Katherine H.;
    • Wright, John J.;
    • Šimėnas, Mantas;
    • Thiemann, Jacqueline;
    • Esteves, Ana M.;
    • McGuire, Gemma;
    • Myers, William K.;
    • Morton, John J. L.;
    • Hippler, Michael;
    • Nowaczyk, Marc M.;
    • Hanke, Guy T.;
    • Roessler, Maxie M.
    Publication type:
    Article
    9

    A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates.

    Published in:
    PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0015588
    By:
    • Ott, Patrick A.;
    • Hamilton, Anne;
    • Min, Christina;
    • Safarzadeh-Amiri, Sara;
    • Goldberg, Lauren;
    • Yoon, Joanne;
    • Yee, Herman;
    • Buckley, Michael;
    • Christos, Paul J.;
    • Wright, John J.;
    • Polsky, David;
    • Osman, Iman;
    • Liebes, Leonard;
    • Pavlick, Anna C.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 4, p. 643, doi. 10.1007/s00280-021-04317-y
    By:
    • Maguire, William F.;
    • Schmitz, John C.;
    • Scemama, Jonas;
    • Czambel, Ken;
    • Lin, Yan;
    • Green, Anthony G.;
    • Wu, Shaoyu;
    • Lin, Huang;
    • Puhalla, Shannon;
    • Rhee, John;
    • Stoller, Ronald;
    • Tawbi, Hussein;
    • Lee, James J.;
    • Wright, John J.;
    • Beumer, Jan H.;
    • Chu, Edward;
    • Appleman, Leonard J.
    Publication type:
    Article
    20
    21

    A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 207, doi. 10.1007/s00280-006-0259-9
    By:
    • Ma, Cynthia;
    • Mandrekar, Sumithra J.;
    • Alberts, Steven R.;
    • Croghan, Gary A.;
    • Jatoi, Aminah;
    • Reid, Joel M.;
    • Hanson, Lorelei J.;
    • Bruzek, Laura;
    • Tan, Angelina D.;
    • Pitot, Henry C.;
    • Erlichman, Charles;
    • Wright, John J.;
    • Adjei, Alex A.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Lymphoblastic transformation of myelodysplastic syndrome.

    Published in:
    American Journal of Hematology, 1986, v. 22, n. 4, p. 431, doi. 10.1002/ajh.2830220413
    By:
    • Ascensao, Joao L.;
    • Kay, Neil E.;
    • Wright, John J.;
    • Arthur, Diane;
    • Finkel, Barbara;
    • Rydell, Robert;
    • Kaplan, Manuel E.
    Publication type:
    Article
    28
    29
    30

    Structure of inhibitor-bound mammalian complex I.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-18950-3
    By:
    • Bridges, Hannah R.;
    • Fedor, Justin G.;
    • Blaza, James N.;
    • Di Luca, Andrea;
    • Jussupow, Alexander;
    • Jarman, Owen D.;
    • Wright, John J.;
    • Agip, Ahmed-Noor A.;
    • Gamiz-Hernandez, Ana P.;
    • Roessler, Maxie M.;
    • Kaila, Ville R. I.;
    • Hirst, Judy
    Publication type:
    Article
    31
    32
    33
    34

    A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.

    Published in:
    Oncologist, 2017, v. 22, n. 5, p. 505, doi. 10.1634/theoncologist.2016-0486
    By:
    • Uldrick, Thomas S.;
    • Gonçalves, Priscila H.;
    • Wyvill, Kathleen M.;
    • Peer, Cody J.;
    • Bernstein, Wendy;
    • Aleman, Karen;
    • Polizzotto, Mark N.;
    • Venzon, David;
    • Steinberg, Seth M.;
    • Marshall, Vickie;
    • Whitby, Denise;
    • Little, Richard F.;
    • Wright, John J.;
    • Rudek, Michelle A.;
    • Figg, William D.;
    • Yarchoan, Robert
    Publication type:
    Article
    35
    36

    Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre phase 2 clinical trial

    Published in:
    British Journal of Haematology, 2009, v. 145, n. 1, p. 34, doi. 10.1111/j.1365-2141.2008.07466.x
    By:
    • O'Connor, Owen A.;
    • Moskowitz, Craig;
    • Portlock, Carol;
    • Hamlin, Paul;
    • Straus, David;
    • Dumitrescu, Otilia;
    • Sarasohn, Debra;
    • Gonen, Mithat;
    • Butos, John;
    • Neylon, Ellen;
    • Hamelers, Rachel;
    • Mac-Gregor Cortelli, Barbara;
    • Blumel, Susan;
    • Zelenetz, Andrew D.;
    • Gordon, Leo;
    • Wright, John J.;
    • Vose, Julie;
    • Cooper, Brenda;
    • Winter, Jane
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 6, p. 1577, doi. 10.1007/s10637-021-01138-x
    By:
    • Kummar, Shivaani;
    • Srivastava, Apurva K.;
    • Navas, Tony;
    • Cecchi, Fabiola;
    • Lee, Young H.;
    • Bottaro, Donald P.;
    • Park, Sook Ryun;
    • Do, Khanh T.;
    • Jeong, Woondong;
    • Johnson, Barry C.;
    • Voth, Andrea R.;
    • Rubinstein, Larry;
    • Wright, John J.;
    • Parchment, Ralph E.;
    • Doroshow, James H.;
    • Chen, Alice P.
    Publication type:
    Article
    48

    Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium – an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 3, p. 812, doi. 10.1007/s10637-020-01038-6
    By:
    • Quinn, David I.;
    • Tsao-Wei, Denice D.;
    • Twardowski, Przemyslaw;
    • Aparicio, Ana M.;
    • Frankel, Paul;
    • Chatta, Gurkamal;
    • Wright, John J.;
    • Groshen, Susan G.;
    • Khoo, Stella;
    • Lenz, Heinz-Josef;
    • Lara, Primo N.;
    • Gandara, David R.;
    • Newman, Edward
    Publication type:
    Article
    49

    Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.

    Published in:
    Neuro-Oncology, 2014, v. 16, n. 5, p. 707, doi. 10.1093/neuonc/nou004
    By:
    • Widemann, Brigitte C.;
    • Dombi, Eva;
    • Gillespie, Andrea;
    • Wolters, Pamela L.;
    • Belasco, Jean;
    • Goldman, Stewart;
    • Korf, Bruce R.;
    • Solomon, Jeffrey;
    • Martin, Staci;
    • Salzer, Wanda;
    • Fox, Elizabeth;
    • Patronas, Nicholas;
    • Kieran, Mark W.;
    • Perentesis, John P.;
    • Reddy, Alyssa;
    • Wright, John J.;
    • Kim, AeRang;
    • Steinberg, Seth M.;
    • Balis, Frank M.
    Publication type:
    Article
    50

    Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.

    Published in:
    Neuro-Oncology, 2014, v. 16, n. 4, p. 567, doi. 10.1093/neuonc/not247
    By:
    • Wen, Patrick Y.;
    • Chang, Susan M.;
    • Lamborn, Kathleen R.;
    • Kuhn, John G.;
    • Norden, Andrew D.;
    • Cloughesy, Timothy F.;
    • Robins, H. Ian;
    • Lieberman, Frank S.;
    • Gilbert, Mark R.;
    • Mehta, Minesh P.;
    • Drappatz, Jan;
    • Groves, Morris D.;
    • Santagata, Sandro;
    • Ligon, Azra H.;
    • Yung, W.K. Alfred;
    • Wright, John J.;
    • Dancey, Janet;
    • Aldape, Kenneth D.;
    • Prados, Michael D.;
    • Ligon, Keith L.
    Publication type:
    Article